메뉴 건너뛰기




Volumn 31, Issue 6, 1996, Pages 941-946

Limitation of myocardial infarct size in the rabbit by ischaemic preconditioning is abolished by sodium 5-hydroxydecanoate

Author keywords

5 Hydroxydecanoate; Myocardial infarct size; Myocardial infarction; Myocardial ischemia; Potassium channel, ATP sensitive; Preconditioning; Rabbit, anesthetized

Indexed keywords

5 HYDROXYDECANOIC ACID; HYDROXYACID; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

EID: 0029895234     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00041-7     Document Type: Article
Times cited : (75)

References (32)
  • 1
    • 0022970945 scopus 로고
    • Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
    • Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
    • (1986) Circulation , vol.74 , pp. 1124-1136
    • Murry, C.E.1    Jennings, R.B.2    Reimer, K.A.3
  • 2
    • 0028182641 scopus 로고
    • ATP channels in ischaemic preconditioning
    • ATP channels in ischaemic preconditioning. Cardiovasc Res 1994;28:783-787.
    • (1994) Cardiovasc Res , vol.28 , pp. 783-787
    • Parratt, J.R.1    Kane, K.A.2
  • 3
    • 0026490398 scopus 로고
    • Ischemic preconditioning protects against infarction in the rat heart
    • Liu GS, Downey JM. Ischemic preconditioning protects against infarction in the rat heart. Am J Physiol 1992;263:H1107-12.
    • (1992) Am J Physiol , vol.263
    • Liu, G.S.1    Downey, J.M.2
  • 4
    • 0025999672 scopus 로고
    • Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits
    • Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991;84:341-9.
    • (1991) Circulation , vol.84 , pp. 341-349
    • Cohen, M.V.1    Liu, G.S.2    Downey, J.M.3
  • 5
    • 85047677669 scopus 로고
    • Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.
    • Auchampach JA, Grover GJ, Gross GJ. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 1992;26:1054-62.
    • (1992) Cardiovasc Res , vol.26 , pp. 1054-1062
    • Auchampach, J.A.1    Grover, G.J.2    Gross, G.J.3
  • 6
    • 0025219050 scopus 로고
    • Ischemic preconditioning reduces infarct size in swine myocardium
    • Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-42.
    • (1990) Circ Res , vol.66 , pp. 1133-1142
    • Schott, R.J.1    Rohmann, S.2    Braun, E.R.3    Schaper, W.4
  • 7
    • 0026547286 scopus 로고
    • Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
    • Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-33.
    • (1992) Circ Res , vol.70 , pp. 223-233
    • Gross, G.J.1    Auchampach, J.A.2
  • 8
    • 85047678046 scopus 로고
    • Preconditioning: State of the art myocardial protection
    • Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 1993;27:542-550.
    • (1993) Cardiovasc Res , vol.27 , pp. 542-550
    • Lawson, C.S.1    Downey, J.M.2
  • 9
    • 0027240733 scopus 로고
    • Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts
    • Thornton JD, Thornton CS, Sterling DL, Downey JM. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res 1993;72:44-9.
    • (1993) Circ Res , vol.72 , pp. 44-49
    • Thornton, J.D.1    Thornton, C.S.2    Sterling, D.L.3    Downey, J.M.4
  • 10
    • 0027285011 scopus 로고
    • Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide
    • Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res 1993;27:617-22.
    • (1993) Cardiovasc Res , vol.27 , pp. 617-622
    • Toombs, C.F.1    Moore, T.L.2    Shebuski, R.J.3
  • 12
    • 0028909798 scopus 로고
    • Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anaesthetized with xylazine/pentobarbital but not with pentobarbital alone
    • Miura T, Goto M, Miki T, Sakamoto J, Shimamoto K, Iimura O. Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anaesthetized with xylazine/pentobarbital but not with pentobarbital alone. J Cardiovasc Pharmacol 1995;25:531-8.
    • (1995) J Cardiovasc Pharmacol , vol.25 , pp. 531-538
    • Miura, T.1    Goto, M.2    Miki, T.3    Sakamoto, J.4    Shimamoto, K.5    Iimura, O.6
  • 15
    • 0024339582 scopus 로고
    • Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion
    • Thiemermann C, Thomas RG, Vane JR. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion. Br J Pharmacol 1989;97:401-8.
    • (1989) Br J Pharmacol , vol.97 , pp. 401-408
    • Thiemermann, C.1    Thomas, R.G.2    Vane, J.R.3
  • 16
    • 0028429949 scopus 로고
    • A receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion
    • A receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion. Br. J Pharmacol 1994;112:75-80.
    • (1994) Br. J Pharmacol , vol.112 , pp. 75-80
    • McMurdo, L.1    Thiemermann, C.2    Vane, J.R.3
  • 17
    • 33749913679 scopus 로고
    • Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction
    • Maxwell MP, Hearse DJ, Yellon DJ. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737-46.
    • (1987) Cardiovasc Res , vol.21 , pp. 737-746
    • Maxwell, M.P.1    Hearse, D.J.2    Yellon, D.J.3
  • 18
    • 0019508591 scopus 로고
    • A critical look at currently used indices of myocardial oxygen consumption
    • Baller D, Bretschneider HJ, Hellige G. A critical look at currently used indices of myocardial oxygen consumption. Basic Res Cardiol 1981;76:163-81.
    • (1981) Basic Res Cardiol , vol.76 , pp. 163-181
    • Baller, D.1    Bretschneider, H.J.2    Hellige, G.3
  • 19
    • 0001120360 scopus 로고
    • Macroscopic identification of early myocardial infarct by alterations in dehydrogenase activity
    • Nachlas MM, Shnitka TK. Macroscopic identification of early myocardial infarct by alterations in dehydrogenase activity. Am J Pathol 1963;43:379-405.
    • (1963) Am J Pathol , vol.43 , pp. 379-405
    • Nachlas, M.M.1    Shnitka, T.K.2
  • 22
    • 0028971593 scopus 로고
    • 0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels
    • 0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br J Pharmacol 1995;116:2435-2440.
    • (1995) Br J Pharmacol , vol.116 , pp. 2435-2440
    • Hide, E.J.1    Ney, P.2    Piper, J.3    Thiemermann, C.4    Vane, J.R.5
  • 23
    • 0028876411 scopus 로고
    • Endothelin-1 reduces myocardial infarct size by activating ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion
    • Hide EJ, Piper J, Thiemermann C. Endothelin-1 reduces myocardial infarct size by activating ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion. Br. J. Pharmacol. 1995;116:2597-2602.
    • (1995) Br. J. Pharmacol. , vol.116 , pp. 2597-2602
    • Hide, E.J.1    Piper, J.2    Thiemermann, C.3
  • 26
    • 0025696538 scopus 로고
    • The pharmacologic profile of cromakalim in the treatment of myocardial ischaemia in isolated rat hearts and anaesthetised dogs
    • Grover GJ, Sleph PG, Dzwonczyk S. The pharmacologic profile of cromakalim in the treatment of myocardial ischaemia in isolated rat hearts and anaesthetised dogs. J Cardiovasc Res 1990;16:853-64.
    • (1990) J Cardiovasc Res , vol.16 , pp. 853-864
    • Grover, G.J.1    Sleph, P.G.2    Dzwonczyk, S.3
  • 27
    • 0028968801 scopus 로고
    • Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat
    • Wu CC, Thiemermann C, Vane JR. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat. Br J Pharmacol 1995;114:1273-81.
    • (1995) Br J Pharmacol , vol.114 , pp. 1273-1281
    • Wu, C.C.1    Thiemermann, C.2    Vane, J.R.3
  • 28
    • 0024460927 scopus 로고
    • Anti-ischaemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with these effects with the potassium channel blocker glyburide
    • Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG. Anti-ischaemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989;251:98-104.
    • (1989) J Pharmacol Exp Ther , vol.251 , pp. 98-104
    • Grover, G.J.1    McCullough, J.R.2    Henry, D.E.3    Conder, M.L.4    Sleph, P.G.5
  • 31
    • 0024460927 scopus 로고
    • The anti-ischaemic effects of the potassium channnel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide
    • Grover GJ, McCullough JR, Henry DE, Condor ML, Sleph PG. The anti-ischaemic effects of the potassium channnel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989;251:98-110.
    • (1989) J Pharmacol Exp Ther , vol.251 , pp. 98-110
    • Grover, G.J.1    McCullough, J.R.2    Henry, D.E.3    Condor, M.L.4    Sleph, P.G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.